President Donald Trump’s pick to serve as the third-ranking official in the US Justice Department, Jessie Liu, withdrew from consideration on Thursday, March 28, after at least one Republican lawmaker objected to her past involvement with a women’s legal group, reported Reuters.
Liu will instead serve as an adviser to Attorney General William Barr and remain in her job as the top federal prosecutor in Washington, spokeswoman Kerri Kupec said. “Jessie will be an integral part of our leadership at the Department,” Barr said in a statement.
Liu served on Trump’s presidential transition team and was unanimously confirmed in 2017 by the Senate to serve as US attorney for the District of Columbia, the largest federal prosecutors’ office in the United States.
Trump said earlier this month he intended to nominate Liu to be associate attorney general – a job that involves overseeing the department’s civil litigation, including antitrust matters, civil rights, and environmental law.
But Republican Senator Mike Lee opposed her nomination due to concerns that she did not oppose abortion, Lee’s spokesman Conn Carroll said. Republicans, who generally oppose a woman’s right to abortion, hold a narrow 12-10 majority on the Senate Judiciary Committee, and without Lee’s support they would have had a difficult time securing a confirmation vote in the Senate.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas